Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MME | P08473 | 2/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | CPA1 | P15085 | 2/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2132525 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL2805307 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL14056387 | 0.97 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Hydrochloric Acid SCHEMBL10578120 | 0.97 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL667846 | 0.97 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Boric Acid SCHEMBL31168108 | 0.93 | ALDH1A1 (0.39) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Alanine SCHEMBL27729429 | 0.91 | ALDH1A1 (0.38) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL5960119 | 0.89 | BHMT (0.37) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL28627379 | 0.85 | EGLN1 (0.35) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL3442583 | 0.82 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2025264553-A1 | COMPOSITION AND METHOD FOR PERFUSING TISSUE | DEKA PRODUCTS LIMITED PARTNERSHIP (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2025-09-18 | — | — | US | claimed |
| US-12343416-B2 | Skin engaging member for razor cartridge comprising skin active ingredient | BIC-VIOLEX S.A. (GR) | 2025-07-01 | — | — | US | claimed |
| CN-120058757-A | Synthesis method of methyl iminodiacetic acid borate compound | 上海泰坦科技股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| US-20250136488-A1 | Extended- and Multimodal-Release Compositions | Finoric LLC | 2025-05-01 | — | — | US | claimed |
| CN-119487140-A | CMP slurry composition for polishing copper barrier layer | YC化工股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-117603771-A | Stable-viscosity and shear-thinning acidic cleaning agent composition | 纳爱斯浙江科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| WO-2024010249-A1 | CMP SLURRY COMPOSITION FOR POLISHING COPPER BARRIER LAYER | 와이씨켐 주식회사 | 2024-01-11 | — | — | WO | claimed |
| CN-116262886-A | Cleaning agent with stain stripping enhancing effect | 纳爱斯浙江科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| US-20080044830-A1 | Three-Dimensional Nanostructured and Microstructured Supports | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2008-02-21 | — | — | US | claimed |
| EP-1691840-A2 | PSMA FORMULATIONS AND USES THEREOF | Psma Development Company, L.L.C. (US) | 2006-08-23 | — | — | EP | claimed |
| WO-2005042029-A2 | PSMA FORMULATIONS AND USES THEREOF | PSMA DEVELOPMENT COMPANY, LLC (US) | 2005-05-12 | — | — | WO | claimed |
| US-20040161776-A1 | PSMA formulations and uses thereof | PSMA DEVELOPMENT COMPANY, LLC | 2004-08-19 | — | — | US | claimed |
| US-20020090581-A1 | Photographic bleach composition and process | EASTMAN KODAK COMPANY | 2002-07-11 | — | — | US | claimed |
| EP-1203994-A2 | Photographic bleach composition and process | EASTMAN KODAK COMPANY (US) | 2002-05-08 | — | — | EP | claimed |
| WO-1999048895-A1 | A PROCESS FOR RECOVERY OF 6-AMINOPENICILLANIC ACID FROM A MOTHER LIQUOR | DSM N.V. (NL) | 1999-09-30 | — | — | WO | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, FABP6 | ALDH1A1 2309/4885LMNA 1568/4885MAPT 3275/4885 |
| US-12343416-B2 | Skin engaging member for razor cartridge comprising skin active ingredient | CUTA, SHARPIN, MMP11 | ALDH1A1 2608/4885LMNA 1249/4885MAPT 3729/4885 |
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, SGMS2 | ALDH1A1 3684/4885LMNA 1721/4885MAPT 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.